PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca(2+)-permeable AMPA receptors

Neurobiol Dis. 2014 Oct:70:43-52. doi: 10.1016/j.nbd.2014.05.023. Epub 2014 Jun 20.

Abstract

An excessive activation of poly(ADP-ribose) polymerases (PARPs) may trigger a form of neuronal death similar to that occurring in neurodegenerative disorders. To investigate this process, we exposed organotypic hippocampal slices to N-methyl-N'-nitro-N'-nitrosoguanidine (MNNG, 100μM for 5min), an alkylating agent widely used to activate PARP-1. MNNG induced a pattern of degeneration of the CA1 pyramidal cells morphologically similar to that observed after a brief period of oxygen and glucose deprivation (OGD). MNNG exposure was also associated with a dramatic increase in PARP-activity and a robust decrease in NAD(+) and ATP content. These effects were prevented by PARP-1 but not PARP-2 inhibitors. In our experimental conditions, cell death was not mediated by AIF translocation (parthanatos) or caspase-dependent apoptotic processes. Furthermore, we found that PARP activation was followed by a significant deterioration of neuronal membrane properties. Using electrophysiological recordings we firstly investigated the suggested ability of ADP-ribose to open TRPM2 channels in MNNG-induced cells death, but the results we obtained showed that TRPM2 channels are not involved. We then studied the involvement of glutamate receptor-ion channel complex and we found that NBQX, a selective AMPA receptor antagonist, was able to effectively prevent CA1 neuronal loss while MK801, a NMDA antagonist, was not active. Moreover, we observed that MNNG treatment increased the ratio of GluA1/GluA2 AMPAR subunit expression, which was associated with an inward rectification of the IV relationship of AMPA sEPSCs in the CA1 but not in the CA3 subfield. Accordingly, 1-naphthyl acetyl spermine (NASPM), a selective blocker of Ca(2+)-permeable GluA2-lacking AMPA receptors, reduced MNNG-induced CA1 pyramidal cell death. In conclusion, our results show that activation of the nuclear enzyme PARP-1 may change the expression of membrane proteins and Ca(2+) permeability of AMPA channels, thus affecting the function and survival of CA1 pyramidal cells.

Keywords: Ca(2+)-permeable AMPA receptors; Cell death; GluA1; Hippocampus; MNNG; Organotypic hippocampal slices; PARP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CA1 Region, Hippocampal / drug effects
  • CA1 Region, Hippocampal / pathology
  • CA1 Region, Hippocampal / physiopathology*
  • CA3 Region, Hippocampal / drug effects
  • CA3 Region, Hippocampal / pathology
  • CA3 Region, Hippocampal / physiopathology
  • Calcium / metabolism
  • Caspases / metabolism
  • Cell Death / drug effects
  • Cell Death / physiology*
  • Glucose / deficiency
  • Hypoxia / chemically induced
  • Hypoxia / drug therapy
  • Hypoxia / pathology
  • Hypoxia / physiopathology
  • Nerve Degeneration / chemically induced
  • Nerve Degeneration / drug therapy
  • Nerve Degeneration / pathology
  • Nerve Degeneration / physiopathology
  • Poly (ADP-Ribose) Polymerase-1
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Poly(ADP-ribose) Polymerases / metabolism*
  • Pyramidal Cells / drug effects
  • Pyramidal Cells / pathology
  • Pyramidal Cells / physiology*
  • Rats, Wistar
  • Receptors, AMPA / metabolism*
  • Receptors, N-Methyl-D-Aspartate / metabolism
  • TRPM Cation Channels / metabolism
  • Tissue Culture Techniques

Substances

  • Poly(ADP-ribose) Polymerase Inhibitors
  • Receptors, AMPA
  • Receptors, N-Methyl-D-Aspartate
  • TRPM Cation Channels
  • Trpm2 protein, rat
  • Parp1 protein, rat
  • Parp2 protein, rat
  • Poly (ADP-Ribose) Polymerase-1
  • Poly(ADP-ribose) Polymerases
  • Caspases
  • Glucose
  • Calcium